1 shares

Depression is approximately five times more prevalent in patients with sickle cell disease (SCD) than in the general...

share

Preliminary data from the ongoing TRANSCEND trial showed that patients with relapsed or refractory diffuse large B-cell lymphoma...

share

The US Food and Drug Administration (FDA) has approved Merck’s PREVYMIS (letermovir) tablets for oral use and injection...

share

Sanofi Genzyme and Principia Biopharma have entered into a license agreement to advance the clinical development of PRN2246, an...

share

While treatment with CD19-directed chimeric antigen receptor (CAR) T cells has demonstrated impressive response rates of over 80%...

share

Data from two patients in an ongoing phase I/II clinical trial of LentiGlobin BB305, a gene therapy for...

share

Sarepta Therapeutics plans to raise $375m through the private placement of convertible senior unsecured notes. Due 15 November 2024,...

share

Biopharmaceutical company Cerenis Therapeutics is set to acquire Lypro Biosciences assets, a portfolio of drug delivery nanotechnology. The...